Finance

Lists
Why is MLTX down ၄.၀၉%?
Dive Deeper
MLTX:NASDAQ
MoonLake Immunotherapeutics
၁၀.၇၉ US$
-၄.၀၉%
(-၀.၄၆) 1D
၁၀.၇၉ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၁၈, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLTX...
Open
၁၁.၁၈ US$
High
၁၁.၂၉ US$
Low
၁၀.၇၈ US$
Mkt. cap
၉၁.၈၃ ကုဋေ
Avg. vol.
၁.၆၈ သန်း
Volume
၁.၃၅ သန်း
52-wk high
၂၃.၂၉ US$
52-wk low
၉.၄၆ US$
EPS
-၃.၆၆ US$
Beta
၁.၁၄
Shares outstanding
၈.၅၁ ကုဋေ
No. of employees
၁၃၀
Open
၁၁.၁၈ US$
High
၁၁.၂၉ US$
Low
၁၀.၇၈ US$
Mkt. cap
၉၁.၈၃ ကုဋေ
Avg. vol.
၁.၆၈ သန်း
Volume
၁.၃၅ သန်း
52-wk high
၂၃.၂၉ US$
52-wk low
၉.၄၆ US$
EPS
-၃.၆၆ US$
Beta
၁.၁၄
Shares outstanding
၈.၅၁ ကုဋေ
No. of employees
၁၃၀
News stories
From web sources and news partners
BigGo Finance
BigGo Finance
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
BeInCrypto
BeInCrypto
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
About MoonLake Immunotherapeutics
CEO-
Employees၁၃၀
Founded၂၀၂၀
HeadquartersZug, Zug, ဆွစ်ဇာလန်
SectorHealth Care
Industry-
Analyst ratings
Based on 9 analysts giving stock ratings to MLTX in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for MLTX in the last 3 months.
Highest
Current ၁၀.၇၉ US$
၅၇.၀၀ US$ (+၄၂၈.၂၇%)
Average
၃၆.၁၃ US$ (+၂၃၄.၈၅%)
Lowest
၁၅.၀၀ US$ (+၃၉.၀၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Smith
Leerink Partners
Buy
Reiterated
၃၀.၀၀ US$
+၁၇၈%
11/16/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၅၀.၀၀ US$
+၃၆၃.၄%
11/09/2026
Andreas Argyrides
Chardan Capital
Buy
Initiated
၅၇.၀၀ US$
+၄၂၈.၃%
11/06/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
၄၀.၀၀ US$
+၂၇၀.၇%
11/04/2026
Julian Harrison
BTIG
Buy
Maintained
၃၀.၀၀ US$
+၁၇၈%
11/04/2026
Yun Zhong
Wedbush
Buy
Maintained
၃၄.၀၀ US$
+၂၁၅.၁%
11/04/2026
Brian Abrahams
RBC Capital
Hold
Maintained
၁၅.၀၀ US$
+၃၉%
11/04/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
10/01/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
၃၃.၀၀ US$
+၂၀၅.၈%
09/30/2026
Serge Belanger
Needham
Buy
Maintained
၃၀.၀၀ US$
+၁၇၈%
08/10/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
၇၀.၀၀ US$
+၅၄၈.၇%
06/22/2026
Richard Law CFA
Goldman Sachs
Sell
Maintained
၁၂.၀၀ US$
+၁၁.၂%
05/11/2026
Andy Chen
Wolfe Research
Buy
Upgraded
၂၄.၀၀ US$
+၁၂၂.၄%
03/23/2026
Samantha Semenkow
Citi
Sell
Maintained
၆.၀၀ US$
-၄၄.၄%
03/20/2026
Qize Ding
Rothschild & Co Redburn
Buy
Upgraded
၄၀.၀၀ US$
+၂၇၀.၇%
03/19/2026
Alex Thompson CFA
Stifel Nicolaus
Hold
Maintained
၁၉.၀၀ US$
+၇၆.၁%
03/01/2026
Yatin Suneja
Guggenheim
Buy
Maintained
၂၀.၀၀ US$
+၈၅.၄%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၅.၆၀ ကုဋေ
၅.၄၅ ကုဋေ
၅.၀၂ ကုဋေ
၆.၈၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၂၁ သန်း
၁.၅၅ ကုဋေ
၁.၁၄ ကုဋေ
၁.၁၀ ကုဋေ
Operating expense
၆.၅၂ ကုဋေ
၇.၀၀ ကုဋေ
၆.၁၇ ကုဋေ
၇.၉၉ ကုဋေ
Total operating expenses
၆.၅၂ ကုဋေ
၇.၀၀ ကုဋေ
၆.၁၇ ကုဋေ
၇.၉၉ ကုဋေ
Operating income
-၆.၅၂ ကုဋေ
-၇.၀၀ ကုဋေ
-၆.၁၇ ကုဋေ
-၇.၉၉ ကုဋေ
Other non operating income
၃.၉၂ သန်း
၃.၁၅ သန်း
၂.၈၇ သန်း
၃.၈၀ သန်း
EBT including unusual items
-၆.၂၈ ကုဋေ
-၆.၉၁ ကုဋေ
-၆.၁၇ ကုဋေ
-၇.၈၉ ကုဋေ
EBT excluding unusual items
-၆.၂၈ ကုဋေ
-၆.၉၁ ကုဋေ
-၆.၁၇ ကုဋေ
-၇.၈၉ ကုဋေ
Income tax expense
၂.၄၈ သိန်း
၆.၂၂ သိန်း
၉.၀၀ သောင်း
၆.၃၁ သိန်း
Effective tax rate
-၀.၄၀%
-၀.၉၀%
-၀.၁၅%
-၀.၈၀%
Other operating expenses
-
-
-
-
Net income
-၆.၂၄ ကုဋေ
-၆.၉၇ ကုဋေ
-၆.၁၈ ကုဋေ
-၇.၉၅ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၉၂
-၀.၉၈
-၀.၈၄
-၀.၉၃
Interest and investment income
-
-
-
-
Interest expense
-၁.၉၉ သန်း
-၂.၂၇ သန်း
-၂.၆၃ သန်း
-၂.၆၆ သန်း
Net interest expenses
-၁.၉၉ သန်း
-၂.၂၇ သန်း
-၂.၆၃ သန်း
-၂.၆၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၆.၄၅ ကုဋေ
-၆.၉၂ ကုဋေ
-၆.၀၈ ကုဋေ
-၇.၈၉ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ